New formulation for drugs controlled release for ophthalmic use

Summary of the technology

CSIC and the University of Zaragoza have developed a new formulation to achieve a controlled and sustained release of different drugs inside the eyeball.
Industrial partners from the ophthalmic or pharmaceutical industry are being sought to collaborate through a patent licence agreement.

CSIC - Consejo Superior de Investigaciones Científicas
CSIC - Consejo Superior de Investigaciones Científicas
CSIC - Consejo Superior de Investigaciones Científicas

Details of the Technology Offer

Inorganic carrier for controlled release of ophthalmic drugs Intravitreal injections are invasive and the associated risks (retinal detachments, opportunistic infections, cataracts) increase when repeated applications are required. The short half-life of substances (drugs) administered via this route requires frequent injections for the maintenance of effective concentrations, in the treatment of chronic eye diseases, with poor patient compliance. In base of the short half-life of the drugs, alternative drug delivery systems and sustained-release inserts are being developed to overcome this limitation by reducing the frequency of injections. Therefore, there is still a need to administering drugs, in a controlled released manner, to the posterior segment of the eye for the treatment of retinal and choroidal diseases. Drug concentration in vitreous (ng/g)

Main innovations and advantages


· The main advantage of the present technology is the very significant reduction of the injections frequency.
· The formulation comes in powder form, but is injected as a transparent colloidal dispersion, making it ideal for intravitreal administration without interfering with the vision.

Intellectual property status

  • Granted Patent
  • Patent application number :-

Related Keywords

  • Biological Sciences
  • Medicine, Human Health
  • Pharmaceutical Products / Drugs
  • Therapeutic
  • Drug delivery and other equipment (including kidney dialysis machines)
  • Ophthalmology, Ear, nose and throat diseases

About CSIC - Consejo Superior de Investigaciones Científicas

The Spanish National Research Council (in Spanish 'Consejo Superior de Investigaciones Científicas (CSIC)') is a government agency for basic and applied scientific research.

It is the largest public research organization in Spain, with presence in all the Autonomous Communities through 126 centers and 145 associated units.

CSIC - Consejo Superior de Investigaciones Científicas

Never miss an update from CSIC - Consejo Superior de Investigaciones Científicas

Create your free account to connect with CSIC - Consejo Superior de Investigaciones Científicas and thousands of other innovative organizations and professionals worldwide

CSIC - Consejo Superior de Investigaciones Científicas

Send a request for information
to CSIC - Consejo Superior de Investigaciones Científicas

About Technology Offers

Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.

Help

Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support